Group One Trading’s F-star Therapeutics, Inc. Common Stock FSTX Stock Holding History

Group One Trading’s Portfolio FSTX Stock Details FSTX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q1	–	Sell	-18,700	Closed	-$118K	–	8271
2022 Q4	$118K	Sell	18,700 -17,800	-49%	-$98.5K	﹤0.01%	4288
2022 Q3	$187K	Buy	36,500 +26,900	+280%	+$169K	﹤0.01%	4208
2022 Q2	$60K	Buy	9,600 +8,300	+638%	+$27.9K	﹤0.01%	5419
2022 Q1	$5K	Buy	+1,300	New	+$4.8K	﹤0.01%	7498
2021 Q4	–	Sell	-1,400	Closed	-$10K	–	9068
2021 Q3	$10K	Buy	+1,400	New	+$9.61K	﹤0.01%	7522

Group One Trading's FSTX Position: Q1 2023 in Review

Group One Trading sold out of F-star Therapeutics, Inc. Common Stock (FSTX) in Q1 2023, closing a stake of 175 shares — an estimated $1.11K sold.

Group One Trading first reported a position in FSTX in Q3 2021 and held it in 2 quarters. The position peaked at $1.11K in Q4 2022. 0 funds tracked by Wall St. Rank hold FSTX as of Q1 2023.

Group One Trading reported no remaining F-star Therapeutics, Inc. Common Stock position as of Q1 2023 after selling out during the quarter.
Group One Trading sold 175 F-star Therapeutics, Inc. Common Stock shares in Q1 2023, an estimated $1.11K.
Group One Trading first reported a position in F-star Therapeutics, Inc. Common Stock in Q3 2021 and held it in 2 quarters.
Group One Trading's F-star Therapeutics, Inc. Common Stock position peaked at $1.11K in Q4 2022.
0 funds tracked by Wall St. Rank held F-star Therapeutics, Inc. Common Stock as of Q1 2023.

Based on Group One Trading's 13F filing for Q1 2023, filed 12 May 2023.